Analyst Price Targets — HOPE
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| October 29, 2025 1:28 pm | Gary Tenner | D.A. Davidson | $14.50 | $10.99 | StreetInsider | Hope Bancorp (HOPE) PT Raised to $14.50 at DA Davidson |
| July 30, 2024 8:27 am | Gary Tenner | D.A. Davidson | $15.00 | $13.17 | StreetInsider | Hope Bancorp (HOPE) PT Raised to $15 at DA Davidson |
| April 30, 2024 6:12 am | Gary Tenner | D.A. Davidson | $12.50 | $9.93 | StreetInsider | DA Davidson Upgrades Hope Bancorp (HOPE) to Buy |
Latest News for HOPE
LOS ANGELES--(BUSINESS WIRE)--Hope Bancorp, Inc. (“the Company”) (NASDAQ: HOPE) today announced that the Company will report financial results for its second quarter and six months ended June 30, 2026, before the markets open on Monday, July 27, 2026.A conference call to discuss financial results for the second quarter ended June 30, 2026, will be held on Monday, July 27, 2026, at 9:30 a.m. Pacific Time / 12:30 p.m.…
Hope Bancorp delivered robust Q1 results, driven by a significant net interest margin expansion and disciplined cost control. HOPE's commercial real estate portfolio remains resilient, with an average LTV of 47% and minimal charge-offs, mitigating CRE risk concerns. The pending Manubank acquisition is expected to boost loans and deposits by 17% and drive EPS accretion of over 20%, with a 23% IRR.
LONDON, ON, June 29, 2026 /PRNewswire/ - VersaBank (TSX: VBNK) (Nasdaq: VBNK) today announced it made a $60,000 donation to The Salvation Army's Harvest Hope Campaign and presented a cheque to The Salvation Army executives in front of approximately 700 people at VersaBank's Summer Celebration event in London, Ontario on Saturday, June 27, 2026. "This economy is proving difficult for many people and I've always felt…
SAN DIEGO, June 26, 2026 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for rare diseases, today announced positive five-year data from its ongoing HOPE-2 Open-Label Extension (OLE) study of Deramiocel, the Company's lead cell therapy candidate for Duchenne Muscular Dystrophy (DMD). The data will be presented at the…
Created by Intelligent Racing Foundation and jointly operated with Beao Group, HOPE AI Challenge brings world's top teams to spark next AI breakthrough
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for HOPE.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.